Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin Starr Insider Profile
4 Followers
Kevin Starr, Director, Ten Percent Owner at Global Blood Therapeutics, holds 320.66K shares in SAGE Therapeutics (Ticker: SAGE), holds 1.11M shares in MyoKardia (Ticker: MYOK), holds 5.20M shares in CytomX Therapeutics (Ticker: CTMX). Most recently, Kevin Starr Bought ― shares of SAGE Therapeutics on Jun 17, 2021 for an estimated value of 999.87K.
Kevin Starr Global Blood Therapeutics (GBT)Director, Ten Percent Owner
Global Blood Therapeutics (GBT)
Director, Ten Percent Owner
Ranked #81,096 out of 98,743 Corporate Insiders
Profitable Transactions
4 out of 14 Profitable Transactions
Average Return
-12.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kevin Starr holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kevin Starr
Kevin Starr's Trading History
Global Blood Therapeutics
Dec 20, 2016
―
Informative Sell
1.74M
$156.55M
MyoKardia
Mar 07, 2018
―
Uninformative Sell
―
$249.62M
Editas Medicine
Sep 07, 2016
Ten Percent Owner
Informative Sell
93.65K
$20.78M
Blueprint Medicines
Dec 21, 2016
Ten Percent Owner
Informative Sell
3.00M
$581.92M
CytomX Therapeutics
Apr 14, 2017
Ten Percent Owner
Informative Sell
463.64K
$10.30M
Agios Pharma
Feb 19, 2015
Director, Ten Percent Owner
Uninformative Buy
―
$6.08M
Larimar Therapeutics
Sep 25, 2015
Director
Uninformative Buy
―
$2.64M
SAGE Therapeutics
Jun 17, 2021
Director
Informative Buy
999.87K
$3.82M
Alnylam Pharma
Nov 13, 2015
Director
Uninformative Sell
7.79M
$0.00
List of latest transactions for each holding click on a transaction to see Kevin Starr's performance on stock
You May Also Like
Kevin Starr insider profile FAQ
What is the percentage of profitable transactions made by Kevin Starr?
The percentage of profitable transactions made by Kevin Starr is 29%.
What is the average return per transaction made by Kevin Starr?
The average return per transaction made by Kevin Starr is -12.80%.
What stocks does Kevin Starr hold?
Kevin Starr holds: GBT, MYOK, EDIT, BPMC, CTMX, AGIO, LRMR, SAGE, ALNY stocks.
What was Kevin Starr’s latest transaction?
Kevin Starr latest transaction was an Informative Buy of $999.87K.
What was Kevin Starr's most profitable transaction?
Kevin Starr’s most profitable transaction was an Informative Buy of SAGE stock on July 17, 2014. The return on the trade was 324.10%.
What is Kevin Starr's role in Global Blood Therapeutics?
Kevin Starr's role in Global Blood Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.